Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9

International Immunopharmacology
Asok MukherjeeSubrata Majumdar

Abstract

Visceral leishmaniasis (VL) caused by the protozoan parasite, Leishmania donovani, is associated with irregular fever, weight loss, hepatosplenomegaly and anemia. The therapeutic arsenal against VL is limited and the recent advent of a novel immunomodulatory drug, Miltefosine has shown promising results for effective treatment of VL but its dependence on Toll like receptors (TLR) has not been explored. In this study, we have shown that the non-cytotoxic dose (5 μM) of Miltefosine could render significant protection corresponding to 88% and 95% reduction in intracellular parasite load at 24 h and 48 h in L. donovani infected THP1 cells. This was accompanied by a strong proinflammatory cytokine response in the form of IFN-γ, IL-12 and TNF-α as evident by enzyme linked immunosorbent assay (ELISA) and real time PCR (RT-PCR). This Miltefosine induced proinflammatory cytokine response in infected THP1 cells was also accompanied by simultaneous 10- and 12-fold increase in TLR4 mRNA and TLR9 mRNA. These changes in cytokine response and TLR expression were also studied in peripheral blood mononuclear cells (PBMC) of VL patients treated with Miltefosine by RT-PCR which showed similar results as in THP1 cells. Thereby, suggesting a probab...Continue Reading

References

Jan 1, 1991·Journal of Cancer Research and Clinical Oncology·P HilgardT Reissmann
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
Jan 1, 1993·Cancer Chemotherapy and Pharmacology·P HilgardC Unger
Feb 1, 1997·Current Opinion in Immunology·R Medzhitov, C A Janeway
May 2, 1998·Biochimica Et Biophysica Acta·G Arthur, R Bittman
Dec 16, 1998·Lancet·S SundarH W Murray
Jun 29, 1999·Clinics in Dermatology·P Desjeux
Dec 10, 1999·The New England Journal of Medicine·T K JhaJ Berman
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S SundarH W Murray
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·S Sundar
Nov 13, 2001·Tropical Medicine & International Health : TM & IH·A Bryceson
Jun 27, 2002·The Journal of Infectious Diseases·Sandip BhattacharyyaSubrata Majumdar
Jan 15, 2004·Emerging Infectious Diseases·Luigi GradoniAldo Scalone
Apr 20, 2005·Trends in Parasitology·Rhea N Coler, Steven G Reed
Aug 31, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Caryn BernJorge Alvar
Feb 7, 2007·The Journal of Experimental Medicine·Charles F AndersonDavid Sacks
Jun 30, 2007·Molecular Immunology·Gabi TheinerManfred B Lutz
Oct 17, 2007·Nature Reviews. Microbiology·François ChappuisMarleen Boelaert
Dec 12, 2007·Infection and Immunity·Felipe F TuonVicente Amato Neto
Sep 12, 2009·The Journal of Infectious Diseases·Gaurav GuptaSubrata Majumdar
May 25, 2010·Journal of Dermatological Science·Felipe Francisco TuonValdir Sabbaga Amato
May 25, 2010·The Journal of Antimicrobial Chemotherapy·Shraddha A SaneSuman Gupta
Jul 1, 2010·International Journal of Experimental Pathology·Camila Silva GuerraSuzana Côrte-Real
Dec 25, 2010·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Avijit SarkarMitali Chatterjee

❮ Previous
Next ❯

Citations

Jul 9, 2013·The Journal of Antimicrobial Chemotherapy·Moumita GhoshSyamal Roy
Aug 27, 2014·Future Microbiology·Forough Khadem, Jude E Uzonna
Jul 21, 2015·Expert Opinion on Therapeutic Targets·Nassim MatinNima Rezaei
Mar 5, 2016·Expert Review of Anti-infective Therapy·Naiara MaranAlexandre Morrot
Aug 29, 2013·Scandinavian Journal of Immunology·S ToloueiS J Hasheminia
Apr 11, 2015·Journal of Immunological Methods·Keerti Jain, N K Jain
Aug 27, 2013·Drug Discovery Today·Keerti Jain, Narendra K Jain
Dec 7, 2014·Journal of Clinical Immunology·Susmita RoyMitali Chatterjee
May 30, 2015·PLoS Neglected Tropical Diseases·Laura Gonzalez-FajardoNancy Gore Saravia
Nov 9, 2016·Parasitology Research·Yasuyuki GotoAyako Morimoto
Jan 30, 2018·Frontiers in Immunology·Wim AdriaensenJohan van Griensven
May 1, 2019·Antimicrobial Agents and Chemotherapy·Semra PalićThomas P C Dorlo
Mar 7, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sonia AndréJérôme Estaquier
Dec 17, 2020·Vaccines·Lu LuKelvin Kai-Wang To
Mar 20, 2021·International Journal of Biological Macromolecules·Shailendra YadavNeena Goyal
Oct 26, 2021·International Journal of Antimicrobial Agents·Semra PalićThomas P C Dorlo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.